髓母细胞瘤的辅助化疗
Adjuvant chemotherapy for medulloblastoma.
作者信息
McIntosh S, Chen M, Sartain P A, Duncan C, Fishburn R, Klatskin E H, Schwartz A D, Venes J L
出版信息
Cancer. 1985 Sep 15;56(6):1316-9. doi: 10.1002/1097-0142(19850915)56:6<1316::aid-cncr2820560616>3.0.co;2-d.
Abstract
The use of adjuvant chemotherapy for cerebellar medulloblastoma is controversial. Twenty-one children and adolescents were treated with adjuvant low-dose cyclophosphamide and vincristine following surgery and radiotherapy. With a mean observation period of 6 years, the disease-free survival is 81%.
摘要
辅助化疗用于小脑髓母细胞瘤的治疗存在争议。21名儿童和青少年在手术和放疗后接受了辅助低剂量环磷酰胺和长春新碱治疗。平均观察期为6年，无病生存率为81%。
Zotero 插件